AUROBINDO PHARMA
|
The Current P/S Ratio of AUROBINDO PHARMA is 2.28.
Share Price | ₹1,083.6 | Apr 24,2024 |
Market Cap | ₹63,488.1 Cr | |
Sales-TTM | ₹27,894.7 Cr | TTM-Consolidated Results |
Price/Sales | 2.28x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of AUROBINDO PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹63,488.1 Cr] as on Apr 24,2024
(/) Sales [ ₹27,894.7 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.28x ]
Thus, for AUROBINDO PHARMA , the investors are currently willing to pay '2.28 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of AUROBINDO PHARMA !
The chart below summarizes the trend in P/S Ratio of AUROBINDO PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of AUROBINDO PHARMA
PS Ratio Performance Analysis for AUROBINDO PHARMA
- AUROBINDO PHARMA 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 1.67x.
- AUROBINDO PHARMA 's operated at median p/e ratio of 1.67x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, AUROBINDO PHARMA 's p/e ratio peaked in Mar2019 at 2.35x.
- AUROBINDO PHARMA 's p/e ratio hit its five-year low in Mar2020 of 1.05x.
How does AUROBINDO PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
AUROBINDO PHARMA | 27,894.7 | 2.28 | 63,488.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 47,444.6 | 7.52 | 356,625.0 |
CIPLA LTD | 25,350.2 | 4.46 | 112,938.0 |
DR REDDYS LABORATORIES LTD | 27,212.5 | 3.65 | 99,276.9 |
ZYDUS LIFESCIENCES LTD | 19,024.2 | 4.94 | 93,921.9 |
DIVIS LABORATORIES LTD | 7,492.8 | 13.52 | 101,315.0 |
MANKIND PHARMA LTD | 9,946.3 | 9.67 | 96,143.2 |
TORRENT PHARMACEUTICALS LTD | 10,474.0 | 8.68 | 90,872.6 |
LUPIN LTD | 19,480.1 | 3.70 | 72,010.8 |
ABBOTT INDIA LTD | 5,753.4 | 9.40 | 54,105.4 |
ALKEM LABORATORIES LTD | 12,634.4 | 4.46 | 56,337.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs AUROBINDO PHARMA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.28x |
Max industry PS | 13.52x |
Median industry PS | 4.94x |
Average industry PS | 6.57x |
You may also like the below Video Courses